This article does not
cite any
sources. Please help
improve this article by
adding citations to reliable sources. Unsourced material may be challenged and
removed. Find sources: "List of CP cannabinoids" – news · newspapers · books · scholar · JSTOR (May 2016) ( Learn how and when to remove this message) |
Many synthetic cannabinoids were designed by Pfizer in the 1970s and 1980s, and feature an alphanumeric code beginning with the prefix "CP" (after Charles Pfizer). Recently, several members of this class of cannabinoids have been discovered in recreational drug products.
This article does not
cite any
sources. Please help
improve this article by
adding citations to reliable sources. Unsourced material may be challenged and
removed. Find sources: "List of CP cannabinoids" – news · newspapers · books · scholar · JSTOR (May 2016) ( Learn how and when to remove this message) |
Many synthetic cannabinoids were designed by Pfizer in the 1970s and 1980s, and feature an alphanumeric code beginning with the prefix "CP" (after Charles Pfizer). Recently, several members of this class of cannabinoids have been discovered in recreational drug products.
Phytocannabinoids ( comparison) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endocannabinoids |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Synthetic cannabinoid receptor agonists / neocannabinoids |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Allosteric CBRTooltip Cannabinoid receptor ligands | |||||||||||||||||||||||||||||||||||||||||||||||||||
Endocannabinoid enhancers (inactivation inhibitors) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Anticannabinoids (antagonists/inverse agonists/antibodies) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
|